Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 272-280

  Yi, Bo Rim ^a   Kim, Tae Hee ^b   Kim, Ye Seul ^a   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

E cadherin; EMT; Ovarian cancer; Slug; Snail; Vimentin

Indexed keywords

CADHERIN; TUMOR MARKER; VIMENTIN;

ADENOCARCINOMA; ADULT; AGED; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; OVARY; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84917738659     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2695     Document Type: Article

References (39)

1. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelialmesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
2. Hay ED: The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-720, 2005.
3. Larue L and Bellacosa A: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/ AKT pathways. Oncogene 24: 7443-7454, 2005.
4. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
5. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006.
6. Vares G, Cui X, Wang B, Nakajima T and Nenoi M: Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines. PLoS One 8: e77124, 2008.
7. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
8. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R and Kasimir- Bauer S: Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11: R46, 2009.
9. Kurrey NK, Jalgaonkar SP, Joglekar AV, et al: Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059-2068, 2009.
10. Turley EA, Veiseh M, Radisky DC and Bissell MJ: Mechanisms of disease: epithelial-mesenchymal transition - does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 5: 280-290, 2008.
11. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno- Bueno G and Palacios J: Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68: 989-997, 2008.
12. Hemavathy K, Ashraf SI and Ip YT: Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 257: 1-12, 2000.
13. Ohkubo T and Ozawa M: The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117: 1675-1685, 2004.
14. Savagner P, Kusewitt DF, Carver EA, et al: Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 202: 858-866, 2005.
15. Nakayama K, Nakayama N, Katagiri H and Miyazaki K: Mechanisms of ovarian cancer metastasis: biochemical pathways. Int J Mol Sci 13: 11705-11717, 2012.
16. Batlle E, Sancho E, Franci C, et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
17. Grille SJ, Bellacosa A, Upson J, et al: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003.
18. Auersperg N, Wong AS, Choi KC, Kang SK and Leung PC: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288, 2001.
19. Hipp S, Berg D, Ergin B, et al: Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients. Virchows Arch 457: 705-713, 2010.
20. Okamoto S, Okamoto A, Nikaido T, et al: Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts. Oncol Rep 21: 1209-1214, 2009.
21. Wong AS and Auersperg N: Normal ovarian surface epithelium. Cancer Treat Res 107: 161-183, 2002.
22. Strauss R, Li ZY, Liu Y, et al: Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 6: e16186, 2011.
23. Cho EY, Choi Y, Chae SW, Sohn JH and Ahn GH: Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms. Pathol Int 56: 62-70, 2006.
24. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S and Auersperg N: Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290: C1532-C1542, 2006.
25. Ahmed N, Thompson EW and Quinn MA: Epithelialmesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 213: 581-588, 2007.
26. Demir AY, Groothuis PG, Nap AW, et al: Menstrual effluent induces epithelial-mesenchymal transitions in mesothelial cells. Hum Reprod 19: 21-29, 2004.
27. Symowicz J, Adley BP, Gleason KJ, et al: Engagement of collagen-binding integrins promotes matrix metalloproteinase-9- dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res 67: 2030-2039, 2007.
28. Imai T, Horiuchi A, Shiozawa T, et al: Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 35: 1469-1476, 2004.
29. Sundfeldt K, Ivarsson K, Rask K, Haeger M, Hedin L and Brannstrom M: Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Anticancer Res 21: 65-70, 2001.
30. Vergara D, Merlot B, Lucot JP, et al: Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 291: 59-66, 2010.
31. Liu J, Ikeguchi M, Nakamura S and Kaibara N: Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. J Exp Clin Cancer Res 21: 65-71, 2002.
32. Lengyel E: Ovarian cancer development and metastasis. Am J Pathol 177: 1053-1064, 2010.
33. Elloul S, Elstrand MB, Nesland JM, et al: Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103: 1631-1643, 2005.
34. Patel IS, Madan P, Getsios S, Bertrand MA and MacCalman CD: Cadherin switching in ovarian cancer progression. Int J Cancer 106: 172-177, 2003.
35. Cano A, Perez-Moreno MA, Rodrigo I, et al: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83, 2000.
36. Yin T, Wang C, Liu T, Zhao G, Zha Y and Yang M: Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. J Surg Res 141: 196-203, 2007.
37. Miow QH, Tan TZ, Ye J, et al: Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer. Oncogene: May 26, 2014 (Epub ahead of print) doi: 10.1038/ onc.2014.136.
38. Haslehurst AM, Koti M, Dharsee M, et al: EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 12: 91, 2012.
39. Lo HW, Hsu SC, Xia W, et al: Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67: 9066-9076, 2007.